No substantial psychological impact of the diagnosis of Type 2 diabetes following targeted population screening: The Hoorn Screening Study

Diabetic Medicine

Volumn 21, Issue 9, 2004, Pages 992-998

  Adriaanse, M C ^a,c   Snoek, F J ^a,b   Dekker, J M ^a   Spijkerman, A M W ^a   Nijpels, G ^a   Twisk, J W R ^a   Van Der Ploeg, H M ^a,b   Heine, R J ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Diagnosis; Perceived health status; Psychological well being; Screening; Type 2 diabetes

Indexed keywords

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CONTROLLED STUDY; FEMALE; HEALTH STATUS; HIGH RISK POPULATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; NON INSULIN DEPENDENT DIABETES MELLITUS; PERCEPTION; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; RISK ASSESSMENT; SCORING SYSTEM; SCREENING; WELLBEING;

AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; HEALTH STATUS; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MASS SCREENING; MIDDLE AGED; NETHERLANDS; QUESTIONNAIRES; RISK FACTORS; SELF CONCEPT;

EID: 4544322791     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2004.01276.x     Document Type: Article

References (29)

1. Harris MI. Undiagnosed NIDDM: clinical and public health issues. Diabetes Care 1993; 16: 642-652.
2. UK Prospective Diabetes Study 6. Complications in newly diagnosed type 2 diabetic patients and their association with different clinical and biochemical risk factors. Diabetes Res 1990; 13: 1-11.
3. Goyder EC, Irwig LM. Screening for Type 2 diabetes mellitus: a decision analytic approach. Diabet Med 2000; 17: 469-477.
4. Bastian. H, Keirse. MJNC, Middelton. P, Searle. J. Interventions to influence peoples' experience of screening. The Cochrane Library, Vol. 2, 1999.
5. Lindholt JS, Vammen S, Fasting H, Henneberg EW. Psychological consequences of screening for abdominal aortic aneurysm and conservative treatment of small abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 2000; 20: 79-83.
6. Tymstra T, Bieleman B. The psychosocial impact of mass screening for cardiovascular risk factors. Fam Pract 1987; 4: 287-290.
7. Haynes RB, Sackett DL, Taylor DW, Gibson ES, Johnson AL. Increased absenteeism from work after detection and labeling of hypertensive patients. N Engl J Med 1978; 299: 741-744.
8. Croyle RT, Smith KR, Botkin JR, Baty B, Nash J. Psychological responses to BRCA1 mutation testing: preliminary findings. Health Psychol 1997; 16: 63-72.
9. Tibben A, Duivenvoorden HJ, Niermeijer MF, Vegter-van der Vlis M, Roos RA, Verhage F et al. Psychological effects of presymptomatic DNA testing for Huntington's disease in the Dutch program. Psychosom Med 1994; 56: 526-532.
10. Pugh K, Riccio M, Jadresic D, Burgess AP, Baldeweg T, Catalan J et al. A longitudinal study of the neuropsychiatric consequences of HIV-1 infection in gay men. II. Psychological and health status at baseline and at 12-month follow-up. Psychol Med 1994; 24: 897-904.
11. Knowler WC. Screening for NIDDM. Opportunities for detection, treatment, and prevention. Diabetes Care 1994; 17: 445-450.
12. Marshall KG. The folly of population screening for type 2 diabetes. CMAJ 1999; 160: 1592-1593.
13. Griffin SJ, Little PS, Hales CN, Kinmonth AL, Wareham NJ. Diabetes risk score: towards earlier detection of type 2 diabetes in general practice. Diabetes Metab Res Rev 2000; 16: 164-171.
14. Marteau TM, Kinmonth AL, Thompson S, Pyke S. The psychological impact of cardiovascular screening and intervention in primary care: a problem of false reassurance? British Family Heart Study Group. Br J General Pract 1996; 46: 577-582.
15. Meland E, Laerum E, Maeland JG. Life style intervention in general practice: effects on psychological well-being and patient satisfaction. Qual Life Res 1996; 5: 348-354.
16. Shaw C, Abrams K, Marteau TM. Psychological impact of predicting individuals' risks of illness: a systematic review. Soc Sci Med 1999; 49: 1571-1598.
17. Adriaanse MC, Snoek FJ, Dekker JM, van der Ploeg HM, Heine RJ. Screening for Type 2 diabetes: an exploration of subjects' perceptions regarding diagnosis and procedure. Diabetic Med 2002; 19: 406-411.
18. Spijkerman AM, Adriaanse MC, Dekker JM, Nijpels G, Stehouwer CD, Bouter LM et al. Diabetic patients detected by population-based stepwise screening already have a diabetic cardiovascular risk profile. Diabetes Care 2002; 25: 1784-1789.
19. Ruige JB, de Neeling JN, Kostense PJ, Bouter LM, Heine RJ. Performance of an NIDDM screening questionnaire based on symptoms and risk factors. Diabetes Care 1997; 20: 491-496.
20. Bradley C. The Well-Being Questionnaire. Handbook of Psychology and Diabetes: a Guide to Psychological Measurement in Diabetes Research and Practice. Chur. Switzerland: Harwood Academic 1994, 89-109.
21. Pouwer F, van der Ploeg HM, Ader HJ, Heine RJ, Snoek FJ. The 12-item well-being questionnaire. An evaluation of its validity and reliability in Dutch people with diabetes. Diabetes Care 1999; 22: 2004-2010.
22. Pouwer F, Snoek FJ, van der Ploeg HM, Ader HJ, Heine RJ. Monitoring of psychological well-being in outpatients with diabetes: effects on mood, HbA(1c), and the patient's evaluation of the quality of diabetes care: a randomized controlled trial. Diabetes Care 2001; 24: 1929-1935.
23. Aaronson NK, Muller M, Cohen PD, Essink-Bot ML, Fekkes M, Sanderman R et al. Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol 1998; 51 1055-1068.
24. Wagner EH, Grothaus LC, Sandhu N, Galvin MS, McGregor M, Artz K et al. Chronic care clinics for diabetes in primary care: a system-wide randomized trial. Diabetes Care 2001; 24: 695-700.
25. Owen KR, Shepard M, Stride A, Ellard S, Hattersley AT. Heterogeneity in young adult onset diabetes: aetiology alters clinical characteristics. Diabet Med 2002; 19: 758-761.
26. Ware J, Snow K, Kosinski M, Gandek B. SF-36 Health Survey Manual and Interpretation Guide. Boston, MA: The Health Institute, New England Medical Centre, 1993.
27. Edelman D, Olsen MK, Dudley TK, Harris AC, Oddone EZ. Impact of diabetes screening on quality of life. Diabetes Care 2002; 25: 1022-1026.
28. Pratkanis AR, Greenwald AG, Leippe MR, Baumgardner MH. In search of reliable persuasion effects. III. The sleeper effect is dead. Long live the sleeper effect. J Pers Soc Psychol 1988; 54: 203-218.
29. UK Prospective Diabetes Study Group. Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). Diabetes Care 1999; 22: 1125-1136.